NovoCure Limited Operating Lease, Expense
NovoCure Limited (NVCR) reported Operating Lease, Expense of $12.04 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-02-26
- NovoCure Limited operating lease, expense for the quarter ending 2019-12-31 was $1.61M.
- NovoCure Limited operating lease, expense for the quarter ending 2019-09-30 was $1.43M.
- NovoCure Limited operating lease, expense for the quarter ending 2019-06-30 was $634.00K.
- NovoCure Limited operating lease, expense for the quarter ending 2019-03-31 was $1.74M.
- NovoCure Limited operating lease, expense for fiscal 2025 was $12.04M, a 30.23% increase from fiscal 2024.
- NovoCure Limited operating lease, expense for fiscal 2024 was $9.24M, a 12.79% increase from fiscal 2023.
- NovoCure Limited operating lease, expense for fiscal 2023 was $8.20M, a 15.31% increase from fiscal 2022.
- NovoCure Limited operating lease, expense for fiscal 2022 was $7.11M, a 3.28% decline from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $12.04M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $9.24M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $8.20M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $7.11M 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $7.35M 10-K · filed 2024-02-22 | |||
| 2020-12-31 | $5.95M 10-K · filed 2023-02-23 | |||
| 2019-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $3.04M derived: sum of 2 quarters · filed 2022-02-24 | $3.67M derived: sum of 3 quarters · filed 2022-02-24 | $5.41M 10-K · filed 2022-02-24 |
| 2019-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $2.06M derived: sum of 2 quarters · filed 2019-10-31 | $3.80M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $634.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $2.37M 10-Q · filed 2019-07-25 | ||
| 2019-03-31 | $1.74M 10-Q · filed 2019-05-02 | |||
| 2018-12-31 | $4.03M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |